Clinical trial
Levocarnitine in Treating Fatigue in Cancer Patients
NCT00091169 · ECOG-ACRIN Cancer Research Group, Other · Completed
Key facts
| NCT number | NCT00091169 |
|---|---|
| Title | Levocarnitine in Treating Fatigue in Cancer Patients |
| Official title | Phase III Randomized Placebo-Controlled Trial to Determine Efficacy of Levocarnitine for Fatigue in Patients With Cancer |
| Lead sponsor | ECOG-ACRIN Cancer Research Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fatigue, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement, Other |
| Interventions | levocarnitine, placebo |
| Enrollment | 376 |
| Start date | Dec 16, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | May 1, 2011 |
| First posted | Sep 8, 2004 |
| Last update posted | Jul 5, 2023 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: